Sustainable Development Leadership Committee

Bridging the Gap Between Biomedical Sciences and Business

The Sustainable Development Leadership Committee is a multidisciplinary group of individuals located throughout the globe in the United States, Jamaica and Zimbabwe. The committee's main objective is to continue to develop sustainable corporate and university partnerships in order to continue the advancement of clinical research, address pressing health inequities and engage students in experiential learning projects.

University of the West Indies Faculty visiting the University at Buffalo to meet with SUNY and BJIE members.

Committee Members

Last updated: January 2021

Lauren Barredo

Head of Partnerships, Sustainable Development Solutions Network

Lauren Barredo is Head of Partnerships for the SDSN, where she manages relationships with institutions, companies, and individuals, finding new ways to collaborate on SDG implementation. In addition, she manages three Thematic Networks (Health, Agriculture, and Extractive and Land Resources) as well as three Regional Networks (Amazon, Australia Pacific, and Caribbean).

Robin DiFrancesco

Scientific Manager, CIGBS, University at Buffalo

Robin DiFrancesco, MT ASCP, MBA has over 30 years of experience in pharmacology research (20+ in HIV research) and has a variety of knowledge, practical and theoretical, to offer our global students. She is appointed at the UB School of Pharmacy and Pharmaceutical Sciences as a research assistant professor and as a voluntary adjunct faculty member for the UB Department of Biotechnology and Clinical Sciences within the Jacobs School of Medicine and Biomedical Sciences. She holds an ACSP certification as a medical technologist and a NYS license as a clinical laboratory technologist.

Andrew Talal.

Karl Donn, PhD

Vice President of the Drug Development Parion Sciences, Vice President of Pulmonary Development

Karl Donn is currently Vice President, Respiratory R&D. He led the drug discovery program that resulted in the selection of P-1037 as a potent and durable epithelial sodium channel blocker for inhaled delivery to patients with cystic fibrosis, COPD and other respiratory diseases. He continues to lead the development of P-1037 through clinical trials. He also leads tPAD clinical development and led a variety of discovery and early development programs for at Parion. Karl has over 30 years of drug development experience in both small and large pharmaceutical companies. 

Andrew Talal.

Ative Ennis

Head of Innovation and Enterprise Solutions, Digicel

Former director of Innovation and Enterprise Solutions for Digicel Business, Ative Ennis, will lead product development and will drive an improved customer experience in his new role as commercial director (B2B) for Digicel Business. Morin stated, “Ative will add his significant experience in business technology modernisation to help companies leverage their data assets for profitability. Delroy has been instrumental to developing a truly unbeatable fibre-to-the-home service for our customers to experience the speed and benefits of a new phase of Internet connectivity. Together, they will strengthen our leadership team as we work to deepen our relationship with our customers.”

Andrew Talal.

Matt Enstice

Current President and CEO of the Buffalo Niagara Medical Campus, Inc, Matt Enstice leads this pioneering organization that has become a powerful engine of revitalization in Buffalo. He is focused on the intersection of energy, entrepreneurship and technology, and how it will drive the new economy in Buffalo and beyond.

Chief Executive Officer, Buffalo Niagara Medical Campus

Andrew Talal.

Garthfield Gibson

Comptroller, Spectrum Radiology Associates

Gibson serves as the comptroller for Spectrum Radiology Associates. Members of the board of trustees are principally charged with the strategic, long-term protection and strengthening of the financial, physical and programmatic assets of the school, while manifesting the mission of the school. Board members have a three-year term, and serve on at least one standing committee of the board.

Andrew Talal.

John Hatcher

Vice President of Business Development, Accessium Group

John Mead Hatcher, President of JMH Advisement, LLC, has over 35 years of experience in business development and brings his vast network of contacts within the specific fields of finance, research, politics and business associations together to enable startups, early-stage, as well as, full-fledged operating companies for the purpose of achieving their business goals and objectives.

Irfan Khan, MD

CEO, Circuit Clinical

Dr. Khan is a Cardiologist and CEO & Founder of Circuit Clinical. Founded in 2015, Circuit Clinical is headquartered in Buffalo, New York, and partners with nationally recognized pharmaceutical and biotechnology companies to research a range of new treatments that could improve patient health and wellbeing. Under Dr. Khan's leadership, Circuit Clinical is leading a mission to transform the way people find, choose, and participate in clinical research by building one of the largest integrated research organizations in the U.S and by creating its award winning technology TrialJourney™, the first ever patient rating and review platform for clinical trials.

Andrew Talal.

Gabriella Heffesse

Chief Operating Officer, ACG Analytics

Gabriella Heffesse joined ACG Analytics in 2014 and focuses on client relations, business development, and analyzing policy effects on capital markets. Since joining ACGA she has led trips for clients to meet with governments and officials in several countries including Greece, Argentina, Germany, and the United States.

Andrew Talal.

John Lindo, PhD

Deputy Dean for Research, University of the West Indies, Mona Campus

Professor Lindo John is a Full Professor of Parasite Epidemiology, Faculty of Medical Sciences at The University of the West Indies (UWI), Mona campus and Deputy Dean (Research). His extensive experience with Vector borne diseases comes in part from a sabbatical year spent with the Neglected Tropical Diseases Unit at the Pan American Health Organization (PAHO) in Washington DC. During his time at PAHO he worked on the elimination of schistosomiasis in the Americas which included a visit to inspect transmission sites in Suriname and facilitating a workshop in Grenada with experts from academia, WHO, CARPHA and CDC.

Andrew Talal.

Charles Chiedza Maponga, PharmD, MPHE

Senior Lecturer and Director, School of Pharmacy, University of Zimbabwe College of Health Sciences

Charles Chiedza Maponga also holds a visiting faculty position with the UB School of Pharmacy and Pharmaceutical Sciences. He travels frequently between UB and the University of Zimbabwe while coordinating the activities of an international collaborative program, the International Pharmacotherapy Education and Research Initiative. Professor Maponga is the University of Zimbabwe's principal investigator for the NIH Fogarty International Center HIV Research Training program. He works to implement a postgraduate and postdoctoral training initiative between the two universities with an emphasis on HIV clinical pharmacology.

Beverly Joy Morrison

President and Chief Executive Officer, Mount Regale Practice Management

Beverly Joy Morrison has worked with nonprofit organizations for 40 years.  She worked with the Episcopal Diocese of Massachusetts at a local church level as well as serving on the Diocesan Council and the Bishop’s Executive Committee.  Her current nonprofit service is in the role of President of Jamaican and American Association of Buffalo and Recording Secretary for National Association of Jamaican and Supportive Organizations.  Morrison is a Board Member of Buffalo Jamaica Innovation Enterprise.  Beverly is President and CEO of a medical practice management company and is passionate in coordinating the care of patients.  She is a graduate of Boston College.  Above all, Beverly is the proud mother of Noelle and Vanessa; grandmother of Marc.

Gene D. Morse, PharmD

Director, Center for Integrated Global Biomedical Sciences

SUNY Distinguished Professor, School of Pharmacy and Pharmaceutical Sciences

Dr. Morse also directs the Translational Pharmacology Research Core in UB's New York State Center of Excellence in Bioinformatics and Life Sciences. He has been actively involved in drug development research since the introduction of antiretrovirals for HIV in 1986, with more recent emphasis on HCV infection and antiviral drug development. He is the principal Investigator for the NIH Fogarty International Center, HIV Research Training Program with the University of Zimbabwe, co-chair of the SUNY-University of the West Indies Faculty Task Force for Health Research Development and chair of the Buffalo Jamaica Innovation Enterprise Executive Committee. Morse is the hub steward for the Western New York Science, Technology, Engineering and Mathematics (STEM) Hub.

Andrew Talal.

William Pearce


Previously President & CEO of Pearce & Pearce Co., Inc., a real estate management and investment firm. Prior to moving to Buffalo in 2000, was Senior Vice President and practice manager at Stern Stewart & Co., a corporate finance advisory firm based in New York City. Current and previous board service includes: 716 Squash (Treasurer); U.B. School of Social Work – Dean’s Advisory Council; Forest Lawn Heritage Foundation; Buffalo Jamaica Innovation Enterprise; Medaille College (Chairman, Advancement Committee; Executive Committee); Buffalo Seminary; Kaleida Health Foundation (Chairman); Buffalo Zoological Gardens capital campaign steering committee; Frank Lloyd Wright’s Fontana Boathouse;. Graduate of Lawrence University with a BA in Government.

Andrew Talal.

Satish Sharma, MD, FACS

Chairman and Chief Executive Officer, You First Services

Dr. Satish Sharma, MD, FACS is the Executive Chairman and Chief Executive Officer of You First Services Group of companies. He is also the Chairman of the Board of Directors of You First Services Group. Dr. Sharma is a clinical, technology and Innovation leader and provides leadership to various programs to enhance productivity, agility and affordability of company operations while expanding national and international operations. Dr. Sharma is also a Research Associate Professor with Department of Urology, Jacobs School of Medicine and Biomedical Sciences, the Clinical Director of Prostate cancer research program, Department of Medicine, Univeristy at Buffalo.

Andrew Talal.

Patrick Sheehan

Co-Founder and Executive Director, Peter Sheehan Diabetes Care Foundation

Son of the late Dr. Peter Sheehan, Patrick Sheehan is Executive Director of PSDCF, a foundation that unites research organizations, health systems, and industry companies to spur innovation that prevents diabetes and its complications, educate patients and professionals, and convene scientific leaders to advance research.

Andrew Talal.

Dorothy Siaw-Asamoah, PhD

Faculty Director of Global Programs, School of Management, University at Buffalo

Dr. Siaw-Asamoah is the UB School of Management's Founding Faculty Director of Global Programs, a newly-formed department that designs both in-person and virtual action learning projects for students to engage in both domestically and abroad. She also holds Board positions within the School of Managemnt Alumni Assocation's (SOMAA) Faculty Relations Committee and Hope for Sisi's Kids (HOSIKIDS) Foundation.

Andrew Talal.

Suzanne Siminski, MS, MBA

Chief Executive Officer, Frontier Science Foundation

Suzanne Siminski has been working in clinical trials data management and related research activities for more than 30 years. Sue has taken a leadership role in the development of Frontier Science’s laboratory data expertise and software. While Director of the New York office, Sue oversaw leadership groups involved in data management, software development, regulatory oversight and key projects. She currently serves as the Frontier Science Principal Investigator for PHACS and CPQA projects, and as co-Principal Investigator of the coordinating center for the C3PNO project, all programs funded by the NIH. As Chief Executive Officer of Frontier Science Foundation, Sue is strategically increasing the repertoire of clinical research services provided by the organization, and actively building global collaborative partnerships with investigators around the world. Sue’s entire CV is available here.

Andrew Talal.

Paul Tesluk, PhD

Dean and Professor, School of Management, University at Buffalo

Chair, Sustainable Leadership Development Committee

Paul Tesluk was named dean of the University at Buffalo School of Management in April 2016. A faculty member since 2011, Tesluk served as chair of the school’s Organization and Human Resources Department. He also founded and served as academic director of the Center for Leadership and Organizational Effectiveness, a university-supported applied research center with a mission to advance both research and practice related to leadership development and organizational effectiveness.